Whittier Trust CO Of Nevada Inc Horizon Therapeutics Public LTD CO Transaction History

Whittier Trust CO Of Nevada Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 21, 2023	SELL	$107.32 - $113.5 $2,039 - $2,156	-19 Reduced 7.82%	224 $24,000
Q4 2022 Jan 25, 2023	BUY	$62.39 - $113.8 $15,160 - $27,653	243 New	243 $0
Q2 2022 Jul 28, 2022	SELL	$79.4 - $116.36 $47,640 - $69,816	-600 Closed	0 $0
Q1 2022 Apr 29, 2022	BUY	$86.42 - $109.81 $51,852 - $65,886	600 New	600 $63,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Whittier Trust CO Of Nevada Inc, based on Form 13F filings with the SEC.

Stay updated on Whittier Trust CO Of Nevada Inc with notifications on news.